|4Mar 4, 5:34 PM ET

Laxai Pharma Ltd 4

4 · Laxai Pharma Ltd · Filed Mar 4, 2011

Insider Transaction Report

Form 4
Period: 2011-02-18
Transactions
  • Other

    Ordinary Shares

    2011-02-18+16,800,00016,800,000 total(indirect: By LLC)
Footnotes (2)
  • [F1]UTA Capital LLC (i) was issued 4,800,000 ordinary shares upon conversion of $240,000 principal amount of indebtedness due from the issuer (ii) was the transferee of an additional 12,000,000 ordinary shares, in each case under a restructuring agreement dated February 18, 2011 (the "Term Sheet"). UTA Capital LLC has no funding obligations in connection with the Term Sheet and the transactions contemplated therein.
  • [F2]This Form 4 is being jointly filed by (i) UTA Capital LLC; (ii) the members or beneficial owners of membership interests in UTA Capital LLC, which include (a) YZT Management LLC, a New Jersey limited liability company and the managing member of UTA Capital LLC, and (b) Alleghany Capital Corporation, a Delaware corporation and a member of UTA Capital LLC; (iii) Alleghany Corporation, a publicly-traded Delaware corporation of which Alleghany Capital Corporation is a wholly-owned subsidiary; and (iv) Udi Toledano, the managing member of YZT Management LLC. The reporting persons disclaim beneficial ownership of these securities except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that any reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Documents

1 file
  • 4
    c13712_4x0.xmlPrimary

    MAIN DOCUMENT DESCRIPTION